Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Danaher Corp (NY:DHR)

199.07 -1.09 (-0.54%)
Streaming Delayed Price Updated: 1:15 PM EDT, Jul 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Danaher Corp

< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
News headline image
1 Cash-Producing Stock with Competitive Advantages and 2 We Brush Off
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient... 
Via StockStory
News headline image
Danaher (DHR) Stock Is Up, What You Need To Know
What Happened? Shares of diversified science and technology company Danaher (NYSE:DHR) jumped 2.8% in the morning session after its recently acquired subsidi... 
Via StockStory
News headline image
3 Healthcare Stocks with Questionable Fundamentals
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have realiz... 
Via StockStory
News headline image
Danaher Is Down 22% This Year. Is the Masimo Acquisition the Entry Point Investors Have Been Waiting for? ↗
The life sciences giant is transforming its diagnostics segment with its acquisition of Masimo Corporation, shifting from traditional laboratory testing into patient-connected, real-time data streams. 
Via The Motley Fool
Topics Artificial Intelligence Earnings Intellectual Property
News headline image
1 Profitable Stock with Promising Prospects and 2 That Underwhelm
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ... 
Via StockStory
News headline image
The Best Stocks to Invest $1,000 in Right Now ↗
Exploring some of the top bargains in a multi-trillion-dollar industry. 
Via The Motley Fool
News headline image
Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner
From Masimo
Via Business Wire
News headline image
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f... 
Via StockStory
News headline image
3 Reasons to Avoid DHR and 1 Stock to Buy Instead
Danaher has gotten torched over the last six months - since December 2025, its stock price has dropped 21.2% to $178.42 per share. This may have investors wo... 
Via StockStory
Stay informed with the top movers within the S&P500 index on Thursday. ↗
Via Chartmill
Gapping S&P500 stocks in Thursday's session ↗
Via Chartmill
News headline image
SCIEX Launches the novus V55 System With SCIEX OS 5.0 Software and AI Enablement Tools
From SCIEX
Via Business Wire
News headline image
SCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key Collaborations
From SCIEX
Via Business Wire
News headline image
Research Tools & Consumables Stocks Q1 Results: Benchmarking Danaher (NYSE:DHR)
Looking back on research tools & consumables stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Danaher (NYSE:DHR) and its p... 
Via StockStory
Topics Economy
News headline image
3 Profitable Stocks We’re Skeptical Of
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi... 
Via StockStory
News headline image
This Stock Is Up Over 52,700% Since Founding. Should Investors Buy After Its 36% Decline? ↗
This blue chip stock has been in a multiyear slump, but things are looking up. 
Via The Motley Fool
Topics Artificial Intelligence
Top gainers and losers in the S&P500 index during Thursday's after-hours session. ↗
Via Chartmill
Thursday's after hours session: top gainers and losers ↗
Via Chartmill
Discover which S&P500 stocks are making waves on Wednesday. ↗
Via Chartmill
News headline image
DHR Q1 Deep Dive: Bioprocessing Momentum and Acquisition Strategy Drive Mixed Start to 2026
Diversified science and technology company Danaher (NYSE:DHR) fell short of the market’s revenue expectations in Q1 CY2026 as sales rose 3.7% year on year to... 
Via StockStory
News headline image
Danaher (DHR) Q1 2026 Earnings Call Transcript ↗
Danaher (DHR) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Danaher Corp. May Be the Smartest Bet in Biotech Right Now ↗
If biotech funding continues to increase this year, Danaher could benefit. 
Via The Motley Fool
Topics Supply Chain
News headline image
Danaher (NYSE:DHR) Misses Q1 CY2026 Revenue Estimates
Diversified science and technology company Danaher (NYSE:DHR) fell short of the market’s revenue expectations in Q1 CY2026 as sales rose 3.7% year on year to... 
Via StockStory
News headline image
Danaher (DHR) Q1 Earnings: What To Expect
Diversified science and technology company Danaher (NYSE:DHR) will be reporting results this Tuesday before market open. Here’s what to expect. Danaher met a... 
Via StockStory
Topics Artificial Intelligence
AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have realized stron... 
Via StockStory
News headline image
Hologic, Inc. (NASDAQ: HOLX): A New Chapter as a Women’s Health Powerhouse
Today marks a definitive turning point for Hologic, Inc. (NASDAQ: HOLX). As the company prepares to finalize its $18.3 billion acquisition by private equity giants Blackstone and TPG, it stands as a... 
Via Finterra
Topics Artificial Intelligence Retirement World Trade
News headline image
AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages
From AINewsWire
Via GlobeNewswire
News headline image
3 Reasons to Avoid DHR and 1 Stock to Buy Instead
Although the S&P 500 is down 2.8% over the past six months, Danaher’s stock price has fallen further to $190.75, losing shareholders 9.3% of their capital. T... 
Via StockStory
Topics Stocks
News headline image
The Often-Missed Corner of Healthcare That Wall Street Is Loving ↗
Via MarketBeat
< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.